A consolidated view of market events, assembled from diverse sources.

EAAA India Alternatives Limited, the alternatives investment arm of Edelweiss Financial Services, launched its IPO on October 26, 2026, structured entirely as an Offer for Sale of up to ₹1,260.57 crore. The company manages India-focused funds across Real Assets and Private Credit, with Fee-Paying AUM growing from ₹3,03,980 million in FY24 to ₹4,86,231 million in Q1 FY27. Total income rose approximately 22.5% YoY in FY26 to ₹9,637.59 million, with Q1 FY27 showing 58.8% YoY growth. Key risks include performance-linked income variability, regulatory changes, talent dependence, and competitive pressure from banks and NBFCs in the private credit segment.
Singapore-based Sembcorp Industries is gauging investor interest for a potential ₹3,750 crore IPO of its Indian renewable energy subsidiary Sembcorp Green Infra Ltd., with the company considering a December 2026 launch. The Temasek Holdings-backed renewable energy company operates 7.6 GW of renewable capacity across 18 states and reported 14.4% revenue growth to ₹2,652.50 crore in FY26.

Electromech Infraprojects Ltd filed its Draft Red Herring Prospectus on October 26, 2026, for a ₹326 crore IPO comprising fresh equity shares and an offer for sale. The company maintains a strong order book of ₹829.72 crore with 87.92% from data centres, demonstrating robust financial performance with ₹427.05 crore revenue and 8.41% PAT margin in fiscal 2026.

Infinx Technology Solutions, a KKR and Norwest Venture Partners-backed healthcare IT company, has appointed Kotak Mahindra Capital, Nomura and Avendus to manage its proposed $300 million IPO in India, targeting a FY28 listing. The AI-powered revenue cycle management firm, founded in 2012, has raised $186 million in total funding and serves US healthcare providers through patient access, billing and collections services.


Shellz India SME shares are set to list on BSE SME on October 23 with a 4% grey market premium, indicating potential 4% listing gains over the issue price of ₹170-179 per share. The IPO was oversubscribed 58.54 times, raising ₹59.97 crore through fresh equity issuance, with strong participation across all investor categories.

Integris Medtech Ltd has reduced its IPO fresh issue from ₹925 crore to ₹600 crore while maintaining an offer-for-sale component of 1.08 crore shares, with 85% of proceeds allocated to debt repayment across subsidiaries. The revised structure reflects the company's strategic focus on strengthening its balance sheet amid current market volatility, with the IPO scheduled to open for subscription on February 24, 2026.

Ravita Engineering Services is set to debut on NSE SME today with a muted grey market premium of around 1%, following a ₹116.05 crore IPO that was oversubscribed 7.11 times during October 14-16, 2026. The company demonstrated strong financial growth with revenue increasing from ₹13.49 crore in FY24 to ₹277.63 crore in FY26, while maintaining an order book of over ₹47,500 lakhs across EPIC, O&M and hybrid projects.

National Stock Exchange shares declined 1% to ₹1,688.80 on Thursday as the one-month lock-in period ended, releasing ₹3,225 crore worth of shares for trading. Despite the current decline, NSE's market capitalisation remains at ₹4.17 lakh crore, ranking it 13th among Indian companies, though the stock is trading 5.38% below its IPO price of ₹1,785.

Nearly 10% of the 97 companies listed in 2026 have delivered returns exceeding 220%, with ESDS Software Solution leading at 220% gains. While analysts attribute strong IPO performance to investor preference for niche businesses, they recommend partial profit booking due to sharp valuation expansions and advise a 'buy on dips' strategy for selective opportunities.

IFC-backed Crystal Crop Protection has reduced its IPO size from ₹600 crore to ₹439.3 crore fresh issue and 37.02 lakh OFS shares, with promoter Ankur Aggarwal as the sole selling shareholder. The Delhi-based agrochemicals and seeds solutions company plans to use ₹335 crore from fresh issue proceeds for debt repayment and acquisitions, while the pre-IPO placement has been scaled down from ₹120 crore to ₹87.86 crore.